MacroGenics | Aktywa



Assets Zmiana Data
AbbVie USD 135.16B 8.26B 2024-12
Amgen USD 89.37B 2.47B 2025-03
AstraZeneca USD 106.25B 2.22B 2025-03
Biogen USD 28.03B 16.2M 2025-03
Bristol-Myers Squibb USD 92.43B 176M 2025-03
Daiichi Sankyo JPY 3.46T 12.51B 2025-03
Eli Lilly USD 89.39B 10.67B 2025-03
Genmab DKK 6.59B 39.22B 2025-03
Geron USD 562.45M 31.33M 2025-03
Gilead Sciences USD 56.43B 2.56B 2025-03
J&J USD 193.67B 13.57B 2025-03
MacroGenics USD 261.65M 2.84M 2024-12
Merck USD 115.12B 1.98B 2025-03
Pfizer USD 208.03B 5.37B 2025-03
Regeneron Pharmaceuticals USD 37.55B 214.2M 2025-03
Roche Holding CHF 101.8B 6.02B 2024-12
Xencor USD 904.69M 47.26M 2025-03



MacroGenics Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.